CTOs on the Move

Strategic Healthcare Programs

www.shpdata.com

 
Strategic Healthcare Programs is a Santa Barbara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.shpdata.com
  • 222 E Canon Perdido St
    Santa Barbara, CA USA 93101
  • Phone: 805.963.9446

Executives

Name Title Contact Details

Similar Companies

Sampling Technologies - STI Smart Technologies

Sampling Technologies - STI Smart Technologies is a Lower Sackville, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Med Arm Inc

Med Arm Inc is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hoya Vision

Driven by a passion for partnership as well as innovation, HOYA has been a partner to Eye Care Professionals for over 75 years, enabling them to give people the greatest gift, the gift of vision. We provide Eye Care Professionals with the lenses, consultation solutions and other services that help them to develop their practice while changing the way people see the world. We see them as visionaries, and everything we do is for them. Founded in Japan in 1941, today, HOYA has a presence in over 80 countries across the globe.

Hilco/Wilson Smart Optical Solutions

Hilco/Wilson Smart Optical Solutions is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Plainville, MA. To find more information about Hilco/Wilson Smart Optical Solutions, please visit www.hilco-usa.com

Glytec System

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.